Evidence map›Paper›PMID 42876995›Full record

ArticleFrontiers in medicine2026

Feature-aware attention convolutional neural network for efficient pulmonary fibrosis classification from chest CT images with FPGA deployment.

K Mahapackialakshmi, G Jaffino

Abstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

K MahapackialakshmiSchool of Electronics Engineering, Vellore Institute of Technology, Vellore, Tamil Nadu, India.
G JaffinoSchool of Electronics Engineering, Vellore Institute of Technology, Vellore, Tamil Nadu, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Pulmonary Fibrosis (PF) is a progressive interstitial lung disease that requires accurate analysis of chest Computed Tomography (CT) images, while conventional image interpretation is time-consuming and dependent on expert assessment. Although deep learning has demonstrated strong performance for automated PF classification, many existing approaches are primarily designed for software-based execution and do not explicitly consider deployment on resource-constrained embedded hardware. Methods: To address this limitation, this study proposes a lightweight Feature-Aware Attention Convolutional Neural Network (FAA-CNN) for binary classification of pulmonary fibrosis and normal CT images with FPGA-oriented design considerations. The proposed architecture integrates multi-level feature fusion and feature-wise attention gating to enhance discriminative feature representation while maintaining a compact computational structure. The trained model is translated into synthesizable VHDL using MATLAB HDL Coder and implemented for the PYNQ-Z2 FPGA with a Zynq-7020 device using Xilinx Vivado. Results and Discussion: Experimental evaluation on 5,120 CT images demonstrates that the proposed FAA-CNN achieves 97.82% accuracy, 97.18% sensitivity, and 98.46% specificity, outperforming the analytical baseline and base CNN. The FPGA implementation achieves timing closure at 47 MHz and utilizes 5,236 LUTs, 4,931 flip-flops, 106.5 BRAM tiles, and 10 DSP48E1 slices. Vivado estimates a total on-chip power of 0.139 W, comprising 0.028 W dynamic and 0.112 W device static power. These results demonstrate the feasibility of combining pulmonary fibrosis image classification with FPGA-oriented implementation.

Indexed as

binary classificationembedded AIFAA-CNNFPGAhardware accelerationmedical imagingPYNQ-z2

Identifiers

PMID42876995
PMCPMC13661921

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.